PIM
ALBO

Platinum Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

Platinum Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-306,834
Closed -$6.63M – 157
2022
Q4 		$6.63M Buy
306,834
+39,917
+15% +$844K 0.25% 45
2022
Q3 		$5.17M Buy
266,917
+38,096
+17% +$788K 0.22% 51
2022
Q2 		$4.54M Sell
228,821
-37,923
-14% -$1M 0.17% 54
2022
Q1 		$7.96M Sell
266,744
-48,918
-15% -$1.43M 0.24% 49
2021
Q4 		$7.35M Buy
315,662
+70,281
+29% +$1.87M 0.2% 53
2021
Q3 		$7.66M Buy
245,381
+39,489
+19% +$1.22M 0.22% 51
2021
Q2 		$7.24M Buy
205,892
+142,771
+226% +$4.64M 0.17% 54
2021
Q1 		$2.23M Buy
+63,121
New +$2.33M 0.05% 83

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Platinum Investment Management's ALBO Position: Q1 2023 in Review

Platinum Investment Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 306,834 shares — an estimated $6.63M sold.

Platinum Investment Management first reported a position in ALBO in Q1 2021 and held it in 8 quarters. The position peaked at $7.96M in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Platinum Investment Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Platinum Investment Management sold 306,834 Albireo Pharma Inc shares in Q1 2023, an estimated $6.63M.
  • Platinum Investment Management first reported a position in Albireo Pharma Inc in Q1 2021 and held it in 8 quarters.
  • Platinum Investment Management's Albireo Pharma Inc position peaked at $7.96M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Platinum Investment Management's 13F filing for Q1 2023, filed 12 May 2023.